In Bold, Smart Move, Merck Makes Roger Perlmutter Its Research Chief, Jettisoning Peter Kim
By:
Forbes Real Time
Roger Perlmutter, who left Merck for Amgen more than a decade ago because he didn't think then-chief executive Ray Gilmartin was moving fast enough to adopt new research-and-development strategies, will return to head the company's research labs.
Roger Perlmutter, who left Merck for Amgen more than a decade ago because he didn't think then-chief executive Ray Gilmartin was moving fast enough to adopt new research-and-development strategies, will return to head the company's research labs.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here